1-iodo-3-(methoxymethoxy)benzene | 474009-16-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-iodo-3-(methoxymethoxy)benzene
• CAS: 474009-16-0
• 化学式: C₈H₉IO₂
• 分子量: 264.063
• InChiKey: AKTLTICCMBBJPF-UHFFFAOYSA-N

物化性质

• 沸点：
  289.6±20.0 °C(Predicted)
• 密度：
  1.667±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-iodo-3-(methoxymethoxy)benzene 在 盐酸 、 甲醇 、 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 苯基脲 、 氢气 、 sodium methylate 、 palladium diacetate 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 氯仿 、 水 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 20.0~110.0 ℃ 、101.33 kPa 条件下， 反应 67.0h， 生成 (E,E)-1-(3-hydroxystyryl)-4-(3,4-dihydroxystyryl)benzene
  参考文献：
  名称：

  Phenolic Bis-styrylbenzenes as β-Amyloid Binding Ligands and Free Radical Scavengers

  摘要：

  Starting from bisphenolic bis-styrylbenzene DF-9 (4), P-amyloid (A beta) binding affinity and specificity for phenolic bis-styrylbenzenes, monostyrylbenzenes, and alkyne controls were determined by fluorescence titration with beta-amyloid peptide A beta(1-40) and a fluorescence assay using APP/PSI transgenic mouse brain sections. Bis-styrylbenzene SA R is derived largely from work on symmetrical compounds. This study is the first to describe A beta binding data for bis-styrylbenzenes unsymmetrical in the outer rings. With one exception, binding affinity and specificity were decreased by adding and/or changing the substitution pattern of phenol functional groups, changing the orientation about the central phenyl ring, replacing the alkene with alkyne bonds, or eliminating the central phenyl ring. The only compound with an A beta binding affinity and specificity comparable to 4 was its 3-hydroxy regioisomer 8. Like 4, 8 crossed the blood brain barrier and bound to A beta plaques in vivo. By use of a DPPH assay, phenol functional groups with papa orientations seem to be a necessary. but insufficient, criterion for good free radical scavenging properties in these compounds.

  DOI：

  10.1021/jm1006929
• 作为产物：
  描述：

  3-碘苯酚 、 氯甲基甲基醚 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 以96%的产率得到1-iodo-3-(methoxymethoxy)benzene
  参考文献：
  名称：

  （-）-amathaspiramide F的全合成。

  摘要：

  海洋生物碱（-）-amathaspiramide F（1）的立体选择性全合成是通过α-羟基-α-乙炔基硅烷2实现的。该合成的关键步骤不仅涉及α-酰氧基-α的烯醇酸克莱森重排。 -烯基硅烷6用于构建含氮的季碳中心，还可以使用七甲基二硅氮烷作为甲胺当量来化学合成氮杂螺旋体胺12，并使用n-Bu（4）NBrCl（2）对12的酚部分进行区域选择性二溴化）。

  DOI：

  10.1021/ol802179e

文献信息

• TROPAN COMPOUND
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1785421A1

  公开（公告）日：2007-05-16

  The conventional anticholinergic drugs for administration through inhalation have been considered to have the possibility of aggravating dysuria associated with prostatic hyperplasia mediated by blood, and it has been demanded that the conventional anticholinergic drugs for administration through inhalation will have to show reduced side effects or adverse ractions. The present invention relates to a compound represented by the general formula (I): (wherein A represents; and R1, R2, R3 and R1 each a hydrogen atom or a substituent; R5 is a substituent; X- is an anion;the symbol: denotes an exo-form or endo-form, or their mixture), its salt or solvation product thereof. They are useful as a prophylactic and/or therapeutic agent with reduced side effects or adverse reactions for the diseases mediated by the muscarinic receptor.

  传统的抗胆碱药物通过吸入给药被认为可能加重与前列腺增生相关的排尿困难，并要求传统的抗胆碱药物通过吸入给药必须显示减少副作用或不良反应。 本发明涉及一种由通式（I）表示的化合物： （其中A代表; 和R1、R2、R3和R1分别是氢原子或取代基; R5是取代基; X-是阴离子;符号: 表示外向型或内向型，或它们的混合物），其盐或溶剂化产物。它们可用作通过胆碱受体介导的疾病的预防和/或治疗剂，具有减少副作用或不良反应。
• [EN] AMPK ACTIVATORS<br/>[FR] ACTIVATEURS D'AMPK
  申请人：KALLYOPE INC

  公开号：WO2021236617A1

  公开（公告）日：2021-11-25

  This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

  这份披露至少部分涉及用于治疗与AMPK相关疾病或疾病的AMPK激活剂。在某些实施例中，该疾病或疾病与肠脑轴有关。在某些实施例中，该疾病或疾病与由于肠道屏障渗漏引起的全身感染和炎症有关。在某些实施例中，AMPK激活剂是肠道限制性化合物。在某些实施例中，AMPK激活剂是激动剂或部分激动剂。
• SELECTIVE ESTROGEN RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE
  申请人：Scanlan Thomas S.

  公开号：US20090124698A1

  公开（公告）日：2009-05-14

  The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.

  本公开涉及一类新型选择性雌激素受体调节剂（SERMs）。该公开还包括先前未知的膜相关雌激素受体的鉴定。公开了制备和使用所述SERMs的方法，包括所述新型化合物的药物配方在有用组合物中的使用。
• Total synthesis of (−)-amathaspiramide F
  作者：Kazuhiko Sakaguchi、Miki Ayabe、Yusuke Watanabe、Takuya Okada、Kazushige Kawamura、Tetsuro Shinada、Yasufumi Ohfune

  DOI：10.1016/j.tet.2009.10.051

  日期：2009.12

  The stereoselective total synthesis of the marine alkaloid, (−)-amathaspiramide F (1), was achieved from the α-hydroxy-α-ethynylsilane 2. The key steps involved in the synthesis were (1) the enolate Claisen rearrangement of the α-acyloxy-α-alkenylsilane for the stereoselective construction of the consecutive C5 and C9 chiral centers of 1 (erythro configuration), (2) the construction of aza-spirohemiaminal

  海洋生物碱（-）-amathaspiramide F（1）的立体选择性全合成是由α-羟基-α-乙炔基硅烷2实现的。合成中涉及的关键步骤是（1）α-酰氧基-α-烯基硅烷的烯醇式Claisen重排，用于立体选择构造连续1个C5和C9手性中心（赤型构型），（2）氮杂的构造-血友病药28，和（3）在总合成的最后阶段进行二溴化。（Z）-α-酰氧基-α-烯基硅烷22的反应具有Boc-高烯丙基甘氨酸酯作为酰氧基的立体选择性烯醇化克莱森重排，得到所需的赤型产物23。另一方面，具有Boc-脯氨酸的α-酰氧基-α-烯基硅烷（Z）-5的反应得到了未预期的苏式产物6。乙烯基硅烷基团23的氧化裂解，然后以七甲基二硅氮烷作为甲胺当量进行处理，得到氮杂螺环血醛缩醛28。有问题的区域选择性二溴化至28是使用实现Ñ -Bu 4 NBrCl 2。
• Palladium-catalyzed incorporation of atmospheric CO₂: efficient synthesis of functionalized oxazolidinones
  作者：Patricia García-Domínguez、Lorenz Fehr、Giulia Rusconi、Cristina Nevado

  DOI：10.1039/c6sc00419a

  日期：——

  organic molecules are on demand. Here we present two Pd-catalyzed multicomponent reactions that provide functionalized oxazolidinones from propargylamines, aryl halides and CO2 as starting materials. These transformations, devoid of high CO2 pressures, represent a streamlined stereocontrolled synthesis of previously inaccessible versions of these useful heterocycles in an atom-economic manner, as up to

  需要将大气中的CO 2掺入有机分子中的方法。在这里，我们介绍了两个Pd催化的多组分反应，这些反应以炔丙基胺，芳基卤化物和CO 2为起始原料提供官能化的恶唑烷酮。这些没有高CO 2压力的转变代表了以原子经济的方式简化了这些有用杂环的先前难以获得的版本的立体控制合成，因为在一个合成操作中最多可以形成四个新的单键。